Conference Proceedings

A Phase 3 randomized Double-blind Study of adjuvant Cemiplimab versus Placebo after Surgery and Radiotherapy for Patients with cutaneous squamous Cell Carcinoma Patients with high Risks

D Rischin, MG Fury, I Lowy, E Stankevich, S Li, H Han, SV Porceddu

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | WILEY | Published : 2020